ACE inhibitor-angiotensin receptor blocker combinations: A clinician's perspective

Mini-Reviews in Medicinal Chemistry

Volumn 6, Issue 5, 2006, Pages 491-497

  Doulton, T W R ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Angiotensin converting enzyme (ACE) inhibitor; Angiotensin receptor blocker; Chronic kidney disease; Diabetic nephropathy; Hypertension; Proteinuria; Renin angiotensin system

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANDESARTAN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; HYDRALAZINE; HYDROCHLOROTHIAZIDE; IRBESARTAN; LISINOPRIL; LOSARTAN; RAMIPRIL; RENIN; TRANDOLAPRIL; VALSARTAN;

ACUTE KIDNEY FAILURE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; DIABETIC NEPHROPATHY; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXCRETION; DRUG METABOLISM; DRUG SAFETY; DRUG STRUCTURE; EVIDENCE BASED MEDICINE; HEART PROTECTION; HUMAN; HYPERKALEMIA; HYPERTENSION; INHIBITION KINETICS; KIDNEY DISEASE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHYSICIAN ATTITUDE; PROTEINURIA; RAT; REVIEW; THEORY; TREATMENT OUTCOME;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; DRUG COMBINATIONS; HUMANS; RECEPTORS, ANGIOTENSIN;

EID: 33646580336     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955706776876168     Document Type: Review

References (62)

1. Chai, S.Y.; Johnston, C.I. In Hypertension: Pathophysiology, Diagnosis and Management (2nd Edition), Laragh, J.H. and Brenner, B.M., Eds.; Raven Press Ltd., New York, 1995; Vol 1, 1683-1693.
2. Coates, D. Int. J. Biochem. Cell Biol. 2003, 35, 769-773.
3. Carey, R.M.; Siragy, H.M. Endocrine Reviews. 2003, 24(3), 261-271.
4. Crowley, S.D.; Tharaux, P.L.; Audoly, L.P.; Coffman, T.M. Acta Physiol. Scand. 2004, 181, 561-570.
5. Johren, O.; Dendorfer, A.; Dominiak, P. Cardiovasc. Res. 2004, 62, 460-467.
6. De Gasparo, M.; Catt, K.J.; Inagami, T.; Wright, J.W.; Unger, T. Pharmacol. Rev., 2000, 52, 415-472.
7. Miura, S.; Saku, K.; Kamik, S.S. Hypertens. Res. 2003, 26, 937-943.
8. Carey, R.M. Curr. Opin. Nephrol. Hypertens., 2005, 14, 67-71.
9. Siragy, M.H. Semin. Nephrol., 2004, 24(2), 93-100.
10. Catt, K.J. In The Renin-Angiotensin System, Robertson JIS; Nicholls MG, Eds.: Gower Medical Publishing, London; 1993; Vol 1, 12.1-12.14.
11. Cushman, D.W.; Cheung, H.S.; Sabo, E.F.; Ondetti, M.A. Biochemistry, 1977, 16, 5484-5491.
12. Jackson, E.K. In The Pharmacological Basic of Therapeutics (10th Edition), Hardman, J.G.; Limbird, L.E.; Gilman, A.G., Eds.: McGraw-Hill, International Edition; 2001, 809-841.
13. Johnston, C.I. In The Renin-Angiotensin System, Robertson, J.I.S; Nicholls, M.G., Eds.: Gower Medical Publishing, London; 1993, Vol 2., 87.1-87.15.
14. Timmermans, P.B.M.W.M.; Wong, P.C.; Chiu, A.T.; Herblin, W.F.; Benfield, P.; Carinin, D.J.; Lee, R.J.; Wexler, R.R.; Saye, J.A.M.; Smith, R.D. Pharmacol. Rev., 1993, 50, 205-251.
15. Burnier, M. Circulation, 2001, 103, 904-912.
16. Siragy, H.M.; Carey, R.M. Hypertension, 1999, 33, 1237-1242.
17. Siragy, H.M.; de Gasparo, M.; Carey, R.M. Hypertension, 2000, 35, 1074-1077.
18. Phoon, S.; Howers, L.G. J. Renin. Angiotensin Aldosterone Syst., 2002, 3: 36-39.
19. Williams, B.; Poulter, N.R.; Brown, M.J.; Davis, M.; McInnes, G.T.; Potter, J.F.; Sever, P.S.; Thom, S.McG. J. Hum. Hypertens., 2004, 18, 139-185.
20. Lewis, E.J.; Hunsicker, L.G.; Bain, R.P.; Rohde, R.D. for the Collaborative Study Group. N. Engl. J. Med., 1993, 329(20), 1456-1462.
21. The GISEN Group. Lancet, 1997, 349, 1857-1863.
22. Ruggenenti, P.; Perna, A.; Gherardi, G.; Giovanni, G.; Zoccali, C.; Salvadri, M.; Scolari, F.; Schena, F.P.; Remuzzi, G. Lancet, 1999, 354, 359-364.
23. The ACE Inhibitors in Diabetic Nephropathy Trialist Group. Ann. Intern. Med., 2001, 134, 370-379.
24. Jafar, T.H.; Schmid, C.H.; Landa, M.; Giatras, I.; Toto, R.; Remuzzi, G.; Maschio, G.; Brenner, B.M.; Kamper, A.; Zuchelli, P.; Becker, G.; Himmelmann, A.; Bannister, K.; Landais, P.; Shahinfar, S.; de Jong, P.E.; de Zeeuw, D.; Lau, J.; Levey, A.S. Ann. Intern. Med., 2001, 135, 73-87.
25. Parving, H-H.; Lehnert, H; Brochner-Mortensen, J.; Gomis, R.; Andersen, S.; Arner, P. N. Engl. J. Med, 2001, 345(12), 870-878.
26. Lewis, E.J.; Hunsicker, L.G.; Clarke, W.R.; Berl, T.; Pohl, M.A.; Lewis, J.B.; Ritz, E.; Atkins, R.C.; Rohde, R.; Raz, I. N. Engl. J. Med., 2001, 345(12), 851-860.
27. Brenner, B.M.; Cooper, M.E.; de Zeeuw, D.; Keane, W.F.; Mitch, W.E.; Parving, H-H.; Remuzzi, G.; Snapinn, S.M.; Zhang, Z.; Shahinfar, S. N. Engl. J. Med., 2001, 345(12), 861-869.
28. Yusuf, S. N. Engl. J. Med., 2000; 342, 145-153.
29. van den Meiracker, A.H.; Main in't Veld, A.J.; Admiraal, P.J.J.; Ritsema van Eck, H.J.; Boomsma, F.; Derkx, F.H.M.; Schalekamp, M.A.D.H. J. Hypertens. 1992, 10, 803-812.
30. Gainer, J.V.; Morrow, J.D.; Loveland, A.; King, D.J.; Brown, N.J. N. Engl. J. Med. 1998, 339, 1285-1292.
31. Jorde, U.P.; Ennezat, P.V.; Lisker, J.; Suryadevara, J.; Infeld, J.; Cukon, S.; Hammer, A.; Sonnenblick, E.H.; Le Jemtel, T.H. Circulation, 2000, 101, 844-846.
32. Mooser, V.; Nussberger, J.; Juillerat, L.; Burnier, M.; Waeber, B.; Bidiville, J.; Pauly, N.; Brunner, H.R. J. Cardiovasc. Pharmacol. 1990, 15, 276-282.
33. Husain, A. J. Hypertens., 1993, 11, 1155-1159.
34. Petrie, M.C.; Padmanabhan, N.; McDonald, J.E.; Hillier, C.; Connell, J.M.C.; McMurray, J.J.V. J. Am. Coll. Cardiol., 2001, 37(4), 1056-1061.
35. Hollenberg, N.K.; Fisher, N.D.L.; Price, D.A. Hypertension, 1998, 32, 387-392.
36. Nussberger, J.; Brunner, D.B.; Waeber, B.; Brunner, H.R. Hypertension, 1985, 7 (Suppl. 1), 1- 1-1-7.
37. De Jong, P.E.; Navis, G.; de Zeeuw, D. Lancet, 1999, 354, 352-353.
38. Mogensen, C.E.; Neldam, S.; Tikkanen, I.; Oren, S.; Viskoper, R.; Watts, R.W.; Cooper, M.E. Br. Med. J. 2000, 321, 1440-1444.
39. Nakao, N.; Yoshimura, A.; Morita, H.; Takada, M.; Kayano, T.; Ideura, T. Lancet. 2003, 361; 117-124.
40. Azizi, M.; Linhart, A.; Alexander, J.; Goldberg, A.; Menten, J.; Sweet, C.; Menard, J. J. Hypertens., 2000, 18, 1139-1147.
41. Doulton, T.W.R.; He, F.J.; MacGregor, G.A. Hypertension. 2005, 45(5), 880-886.
42. Zannad, F.; Matzinger, A.; Larche, J. Am. J. Hypertens. 1996, 6, 633-643.
43. Meredith, P. Blood Press Suppl., 2000, 1, 23 -26.
44. Calvo, C.; Hermida, R.C.; Ayala, D.E.; Ruilope, L.M. J. Hypertens., 2004, 22(4), 837-846.
45. Morgan, T.; Anderson, A.; Bertram, D.; MacInnis, R.J. J. Renin. Angiotensin Aldosterone Syst., 2004, 5, 64-71.
46. Forclaz, A.; Maillard, M.; Nussberger, J.; Brunner, H.R.; Burnier, M. Hypertension, 2003, 41, 31-36
47. Wolf, G.; Ritz, E. Kidney Int. 2005, 67, 799-812.
48. MacGregor, G.A.; Markandu, N.D.; Roulston, J.E.; Jones, J.C.; Morton, J.J. Nature, 1981, 291, 329-330.
49. MacGregor, G.A.; Markandu, N.D.; Roulston J.E. Clin. Sci., 1979, 57, 145s-148s.
50. Wolf, G.; Butzmann, U.; Wenzel, U.O. Nephron. Physiol., 2003, 93, P3-P13.
51. Komine, N.; Khang, S.; Wead, L.M.; Blantz, R.C.; Gabbai, F. Am. J. Kidney Dis., 2002, 39(1), 159-164.
52. Laverman, G.D.; Navis, G.; Henning, R.H.; De Jong, P.E.; De Zeeuw, D. Kidney Int., 2002, 62, 1020-1025.
53. Fujihara, C.K.; Velho, M.; Malheiros, D.M.A.C.; Zatz, R. Kidney Int., 2005, 67, 1913-1924.
54. Weinberg, A.J.; Zappe, D.H.; Ashton, M.; Weinberg, M.S. Am. J. Nephol., 2004, 24(3), 340-345.
55. Griffiths, C.D.; Morgan, T.O.; Delbridge, L.M. J. Hypertens., 2001, 19(11), 2087-2095.
56. Cohn, J.N.; Tognoni, G. for the Valsartan Heart Failure Trial Investigators. N. Engl. J. Med., 2001, 343(23), 1667-1675.
57. Rossing, K.; Jacobsen, P.; Pietrasek, L.; Parving, H-H. Diabetes Care, 2003, 26, 2268-2274.
58. Emanueli, C.; Bonaraia Salis, M.; Stacca, T.; Pintus, G.; Kirchmair, R.; Isner, J.M.; Pinna, A.; Gaspa, L.; Fregoli, D.; Cayla, C.; Pesquero, J.B.; Badmer, M.; Madeddu, P. Circulation, 2002, 105(3), 360-366.
59. Dendorfer, A.; Wolfrum, S.; Dominiak, P. Jpn. J. Pharmacol., 1999, 79, 403-426.
60. Levy, B.I. Circulation, 2004, 109, 8-13.
61. Schiffrin, E.L. Am. J. Med. 2002, 113, 409-418.
62. Burnier, M. Circulation, 2001, 103, 904-912.